Transcatheter Technologies GMBH

Company Summary

Transcatheter Technologies is a medical device company that has developed a full range of transcatheter valve implantation systems for catheter-based heart valve therapy. Provides Aortic and Mitral Valve Implantation (TAVI and TMVI).

Transaction Overview

Asset sale to Venus Medtech, a leading heart valve developer in China.

Significance of the Transaction

Fuel the continued development of the next-generation technology platform for the treatment of various structural heart diseases in the Chinese market. Enhance valve products presence in the global market and expand number of patients that will benefit from the procedure.

Healthios Role

  • This transaction highlights Healthios (Third500) commitment to capital formation in emerging growth companies and our success in completing complex transaction to maximize shareholder interests.
  • Healthios (Third500) served as exclusive financial adviser to Transcatheter Technologies

If you would like to learn more information about this transaction contact us below.

Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.
Mergers & Acquisitions
Transcatheter Technologies GMBH
Has completed a sale of assets to
The undersigned acted as exclusive advisor to Transcatheter Technologies.
Read More